Clinical Trial Update: The DDI Study of SP2086 and Simvastatin [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial update reporting a drug-drug interaction study between SP2086 and simvastatin in Type 2 diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• SIMVASTATIN (SIMVASTATIN)
• SP2086

Snippet

Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Conditions: Type 2 Diabetes | Phase 1 | Status: UNKNOWN